Baseline characteristics of polypoidal choroidal vasculopathy in the EVEREST II Study

被引：0
|
作者：
Lim, Tock H. [1 ]
Feller, Chrystel [2 ]
Margaron, Philippe [2 ]
Tan, Colin S. [1 ,3 ]
机构：
[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore
[2] Novartis Pharma AG, Basel, Switzerland
[3] Natl Healthcare Grp Eye Inst, Fundus Image Reading Ctr, Singapore, Singapore
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
901
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Polypoidal choroidal vasculopathy
    Mori, Fumihiko
    Eguchi, Shuichiro
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (09) : 1104 - 1105
  • [22] TYPICAL POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION
    Jang, Jun Won
    Kim, Jong Min
    Kang, Se Woong
    Kim, Sang Jin
    Bae, Kunho
    Kim, Kyung Tae
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (10): : 1995 - 2003
  • [23] Pilot study of inactive polypoidal lesions in polypoidal choroidal vasculopathy
    Zeng, Renpan
    Zhang, Xiongze
    Li, Meng
    Wen, Feng
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (03) : 222 - 228
  • [24] Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy The EVEREST II Randomized Clinical Trial
    Lim, Tock H.
    Lai, Timothy Y. Y.
    Takahashi, Kanji
    Wong, Tien Y.
    Chen, Lee-Jen
    Ruamviboonsuk, Paisan
    Tan, Colin S.
    Lee, Won Ki
    Cheung, Chui Ming Gemmy
    Ngah, Nor Fariza
    Patalauskaite, Ramune
    Margaron, Philippe
    Koh, Adrian
    JAMA OPHTHALMOLOGY, 2020, 138 (09) : 935 - 942
  • [25] EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study
    Colin S. Tan
    Wei Kiong Ngo
    Louis W. Lim
    Nikolle W. Tan
    Tock H. Lim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1923 - 1930
  • [26] EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    Tan, Nikolle W.
    Lim, Tock H.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (10) : 1923 - 1930
  • [27] Screening failure rates in the EVEREST II clinical trial: challenges in the diagnosis of symptomatic macular polypoidal choroidal vasculopathy
    Tan, Colin S.
    Parikh, Soumil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [28] Clinical characteristics of polypoidal choroidal vasculopathy by hospital based study in Japan
    Haga, M
    Kawasaki, R
    Tsuchiya, D
    Sato, T
    Yamashita, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U622 - U622
  • [29] Comparison of Treatment Outcomes Among Subtypes of Polypoidal Choroidal Vasculopathy in a Multicenter Randomized Controlled Study (EVEREST study)
    Tan, Colin S.
    Lim, Louis Wei Yi
    Ngo, Wei Kiong
    Lim, Tock H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [30] Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Multispectral Imaging
    Zhang, Jie
    Yan, Yan
    Yu, Zikui
    Liu, Lin
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (12): : E249 - E255
12345